Can Psilocybin Help Smokers Quit? This Clinical Trial Aims to Find Out
Mydecine Innovations Group has announced its partnership with the renowned psychedelic science researcher Dr Matthew Johnson of Johns Hopkins University to carry the clinical trial.
Seattle Decriminalizes Psilocybin and Other Psychedelics
The US city of Seattle has become the largest city in the country to decriminalize the use of some psychedelic substances, including psilocybin and mescaline.
Could Ketamine Help Tackle Gambling Addiction?
Recruitment is now underway for a first-of-its-kind study investigating the potential of ketamine to fight gambling addiction.
Ketamine Alone May Effectively Treat Depression, Study Suggests
Ketamine alone may be just as effective as ketamine combined with traditional antidepressants for tackling treatment-resistant depression, a new study has found.
LSD Use is Safe in Healthy Adults, Review Finds
The researchers from the University of Basel concluded that LSD caused no acute psychological or physical harm to the participants.
MDMA Reopens Child-like “Critical Periods” in the Brains of Mice to Promote Mental Healing
Gül Dölen, an associate professor of neuroscience at Johns Hopkins University, explained to Analytical Cannabis just how MDMA-assisted psychotherapy can reopen a “critical period” in the brain for social reward learning.
The Major Magic Mushroom Species You Should Know About
Analytical Cannabis breaks down the traits and effects of the most commonly sought after psychedelic mushrooms.
How Can Psychedelics Be Used to Treat Addiction?
Technology Networks spoke with Professor David Nutt and Anthony Tennyson to discuss the unique considerations of treating addiction and the role of psychotherapy in psychedelic treatments.
New Psychedelic Drugs May Aid in Reducing Alcohol Consumption
Preclinical studies set to investigate the utility of a series of psychedelic-inspired drugs are now underway in Florida.
